Know Cancer

or
forgot password

Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Rectal Cancer

Thank you

Trial Information

Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer


Inclusion Criteria:



- Patients with suspected or biopsy-proven, locally advanced rectal cancer will be
eligible for enrollment.

- Patients must be 18 years or older. Patients must not be pregnant and, if of
child-bearing age, must take precautions not to become pregnant.

- No life expectancy restrictions.

- ECOG and Karnofsky Performance Status will not be employed.

- Patients with renal failure are ineligible for this study (GFR must be > 60)

- Ability to understand and willingness to sign a written informed consent document.

Exclusion Criteria:

- Patients who have undergone prior treatment for rectal cancer are ineligible for
enrollment.

- No restrictions regarding use of other investigational agents.

- Patients with severe contrast allergy are ineligible.

- Patients who are pregnant or are trying to become pregnant are excluded from this
study.

- Patients who are cancer survivors or HIV-positive will not be excluded.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Tumor stage change from Computed Tomography (CT) perfusion measurement

Outcome Time Frame:

3 months

Safety Issue:

No

Principal Investigator

Aya Kamaya

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

REC0006

NCT ID:

NCT01460641

Start Date:

November 2011

Completion Date:

November 2015

Related Keywords:

  • Rectal Cancer
  • Rectal Neoplasms

Name

Location

Stanford University Cancer InstituteStanford, California  94305